Lucid Diagnostics (LUCD) Change in Accured Expenses (2021 - 2026)
Lucid Diagnostics filings provide 5 years of Change in Accured Expenses readings, the most recent being -$122000.0 for Q4 2025.
- On a quarterly basis, Change in Accured Expenses fell 114.81% to -$122000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$110000.0, a 89.13% increase, with the full-year FY2025 number at -$110000.0, up 89.13% from a year prior.
- Change in Accured Expenses hit -$122000.0 in Q4 2025 for Lucid Diagnostics, down from $419000.0 in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $7.7 million in Q4 2022 to a low of -$2.9 million in Q4 2023.
- Median Change in Accured Expenses over the past 5 years was $19000.0 (2022), compared with a mean of $459000.0.
- The widest YoY moves for Change in Accured Expenses: up 16057.89% in 2023, down 254.31% in 2023.
- Lucid Diagnostics' Change in Accured Expenses stood at -$197000.0 in 2021, then surged by 3986.29% to $7.7 million in 2022, then crashed by 138.3% to -$2.9 million in 2023, then surged by 128.1% to $824000.0 in 2024, then tumbled by 114.81% to -$122000.0 in 2025.
- The last three reported values for Change in Accured Expenses were -$122000.0 (Q4 2025), $419000.0 (Q3 2025), and $349000.0 (Q2 2025) per Business Quant data.